Belite Bio Inc - Adr (BLTE) Technical Analysis
$63.12▲1.76%
Market is closed - opens 7 PM, 14 Jul 2025
Insights
- Belite Bio- Adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Belite Bio- Adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Belite Bio- Adr stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Belite Bio- Adr stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 54.69 | Neutral |
Stochastic | 78.52, 79.96 | Neutral |
Ultimate Oscillator | 57.85 | Neutral |
Stochastic Relative Strength Index | 92.42, 86.87 | Neutral |
Moving Average Convergence Divergence | -0.23, -0.7 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 59.54 | Sell |
20 | 59.99 | Sell |
50 | 61.78 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 60.5 | Buy |
20 | 60.48 | Sell |
50 | 60.94 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 59.31 | Buy |
20 | 59.71 | Buy |
50 | 61.56 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 61.09 | Buy |
20 | 60.01 | Sell |
50 | 60.92 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 62.12 | Buy |
20 | 60.22 | Buy |
50 | 59.89 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 71.03 |
Resistance L2 | 67.62 |
Resistance L1 | 65.89 |
Pivot Point | 62.47 |
Support L1 | 60.74 |
Support L2 | 57.33 |
Support L3 | 55.6 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.